Cedars-Sinai Cancer has launched a Clinical and Regulatory Sciences Graduate Certificate Program, which begins in the fall of 2022.
Siteman Cancer Center and University of Missouri Health Care’s Ellis Fischel Cancer Center have formed a collaboration to improve cancer care throughout Missouri.
Gov. Gavin Newsom has signed the California Cancer Care Equity Act (SB 987), a bill that will expand access to specialized cancer care for Medi-Cal patients who receive a complex cancer diagnosis.
Ted Schwartz, a cancer survivor, gifted $15M to City of Hope that will be used entirely to further accelerate immunotherapy research and treatment innovations, such as the CAR T-cell therapy that saved his life.
Jasmin A. Tiro has been named associate director of Cancer Prevention and Population Sciences at University of Chicago Medicine Comprehensive Cancer Center.
NCI has renewed UT Southwestern’s Harold C. Simmons Comprehensive Cancer Center Kidney Cancer Program Specialized Program of Research Excellence award.
The Parker Institute for Cancer Immunotherapy, a network of the largest concentration of immuno-oncology expertise in the world, has added Dana-Farber Cancer Institute and Gladstone Institutes to its network of academic and medical research institutions.
Caris Life Sciences has formed a partnership with Flatiron Health, a healthtech company that helps cancer centers deliver better care for patients.
Louisiana State University Health New Orleans, an NCI-NCORPS designated institution, and ConcertAI, LLC have formed a five-year partnership to improve the diversity of clinical trials and ensure broader clinical trial access throughout the Gulf South region.
The St. Jude Children’s Research Hospital Comprehensive Cancer Center has received a Merit Extension Award from the NCI, extending the center’s current $35 million, five-year Cancer Center Support Grant for an additional two years.
